상세검색
최근 검색어 전체 삭제
다국어입력
즐겨찾기0
대한두경부종양학회지 제39권 제1호.jpg
KCI등재후보 학술저널

두경부암에서 정밀의료

Precision Medicine in Head and Neck Cancer

DOI : 10.21593/kjhno/2023.39.1.1
  • 18

Technological advancement in human genome analysis and ICT (information & communication technologies) brought ‘precision medicine’ into our clinical practice. Precision medicine is a novel medical approach that provides personalized treatments tailored to each individual by precisely segmenting patient populations, based on robust data including a person’s genetic information, disease information, lifestyle information, etc. Precision medicine has a potential to be applied to treating a range of tumors, in addition to non-small cell lung cancer, in which precision oncology has been actively practiced. In this article, we are reviewing precision medicine in head and neck cancer (HNC) with focus on tumor agnostic biomarkers and treatments such as NTRK, MSI-H/dMMR, TMB-H and BRAF V600E, all of which were recently approved by U.S. Food and Drug Administration (FDA).

배경

두경부암의 역학과 병인

두경부암의 치료

정밀의료와 두경부암

결론

References

로딩중